Clinical Trials Browser

Phase 1/2 × Lymphoma, Primary Effusion × pomalidomide × Clear all

NCT02228512 2018-08-31

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Phase 1/2 Withdrawn

Lymphoma, Primary Effusion